← brief for 2026-10-01 · Slowing decline

Effects of SGLT-2 Inhibitors on Plasma Concentrations and Renal Clearance of the Risk Marker Trimethylamine-N-Oxide in Patients With Type-2 Diabetes.

Article No results yet Peer reviewed

Key takeaways

This study looks at how a common diabetes drug affects a specific blood marker. It checks if the drug changes how the body handles this marker. The text does not give the final results.

Who did this work

Zimmer KB · Gessner A · Kannenkeril D · Bosch A · Ströbel A · Schmieder RE · Maas R

Source

Article · PubMed, the drug frontier · 2026 Nov
https://pubmed.ncbi.nlm.nih.gov/42817074/